Trials / Completed
CompletedNCT06655220
A Study in Healthy Men to Test Whether BI 1815368 Influences the Amount of Metformin in the Body
Investigation of the Effect of BI 1815368 on the Pharmacokinetics of Metformin Following Multiple Oral Administration in Healthy Subjects (an Open-label, Randomised, Two-way Crossover Trial)
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 14 (actual)
- Sponsor
- Boehringer Ingelheim · Industry
- Sex
- Male
- Age
- 18 Years – 50 Years
- Healthy volunteers
- Accepted
Summary
The main objective of this trial is to investigate the effect on the exposure of metformin in plasma when administered as an oral multiple dose together with multiple oral doses of BI 1815368 (Test, T) as compared to when metformin is administered as an oral multiple dose alone (Reference, R).
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Metformin hydrochloride | Metformin hydrochloride |
| DRUG | BI 1815368 | BI 1815368 |
Timeline
- Start date
- 2024-11-08
- Primary completion
- 2024-12-08
- Completion
- 2025-01-13
- First posted
- 2024-10-23
- Last updated
- 2025-03-05
Locations
1 site across 1 country: Germany
Source: ClinicalTrials.gov record NCT06655220. Inclusion in this directory is not an endorsement.